Aria Anvar, MD
Hospitalist · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 1
- 1 carrier
- Office
- 1
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Anvar’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence C51613 · Current
Licensed to practise in California · since 2004 · expires 2027-07-31 · University of Toronto Faculty of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$32,087
Medicare paid this office $32,087 for 118 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 67 | $15,550 | $104 |
| Hospital discharge day management, more than 30 minutes | 73 | $7,752 | $102 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 30 | $4,795 | $155 |
| Initial hospital care with same-day admission and discharge with high level of medical decision making, per day at least 85 minutes | 13 | $2,592 | $185 |
Who their Medicare patients are
118 Original Medicare patients in 2024. Average age 79 · Under 65 11% · 85 and older 32% · Women 56% · Also on Medicaid 42% · Health risk score 3.12. Above the middle of the specialty; the typical hospitalist clinician is at 2.49.
Conditions among them: High blood pressure 75% · Heart failure 75% · Coronary heart disease 71% · Atrial fibrillation 63% · Chronic kidney disease 60% · Diabetes 51% · COPD 34% · Dementia 27% · Depression 26% · Cancer 20% · Stroke 19%.
The office billed $135,702, Medicare allowed $40,855 and paid $32,087; for 289 services of 9 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 118 | 289 | 79 | 3.12 | $135,702 | $32,087 |
| 2023 | 80 | 227 | 77 | 2.96 | $135,604 | $21,893 |
| 2022 | 149 | 362 | 77 | 2.24 | $198,355 | $30,292 |
| 2021 | 62 | 196 | 77 | 2.44 | $101,786 | $16,244 |
| 2018 | 22 | 51 | 76 | 3.28 | $16,400 | $3,819 |
| 2017 | 179 | 405 | 76 | 2.28 | $207,573 | $33,498 |
| 2016 | 68 | 108 | 67 | 1.92 | $33,703 | $9,599 |
| 2015 | 39 | 79 | 72 | 1.35 | $21,548 | $6,178 |
| 2014 | 23 | 29 | 75 | 1.74 | $10,394 | $3,127 |
| 2013 | 26 | 45 | 71 | 2.13 | $11,526 | $3,171 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 4 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 54 | $11,156 | $96 |
| Hospital discharge day management, more than 30 minutes | 40 | $3,949 | $96 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 13 | $1,900 | $146 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 14 | $1,351 | $64 |
2022: 7 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 59 | $9,812 | $87 |
| Hospital discharge day management, more than 30 minutes | 72 | $6,560 | $89 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 43 | $3,663 | $60 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 16 | $2,859 | $168 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 19 | $2,317 | $59 |
| Advance care planning, first 30 minutes | 14 | $923 | $66 |
| Hospital observation care on day of discharge | 12 | $734 | $61 |
2021: 4 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 32 | $6,008 | $88 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 23 | $3,811 | $61 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 13 | $2,398 | $171 |
| Hospital discharge day management, more than 30 minutes | 23 | $2,111 | $92 |
2018: 1 service
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 13 | $1,726 | $60 |
2017: 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 53 | $9,389 | $85 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 70 | $7,579 | $60 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 32 | $5,286 | $165 |
| Hospital discharge day management, more than 30 minutes | 57 | $5,176 | $89 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 25 | $2,897 | $116 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 13 | $666 | $33 |
2016: 4 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 17 | $2,789 | $164 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 20 | $2,107 | $84 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 25 | $1,871 | $58 |
| Hospital discharge day management, more than 30 minutes | 11 | $961 | $87 |
2015: 1 service
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 29 | $2,647 | $56 |
2013: 1 service
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 16 | $1,491 | $57 |
Medicaid work
$387 in 2024
Medicaid paid $387 for 12 billed services this clinician did in 2024, up to 12 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Hospital inpatient or observation discharge day management; more than 30 minutes on the date of the encounter | 12 | $387 |
| 2024 | 12 | 1 | 12 | $387 |
| 2023 | 26 | 1 | 14 | $743 |
| 2022 | 17 | 1 | 13 | $301 |
See the largest Medicaid services in earlier years
2023
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 26 | $743 |
2022
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 17 | $301 |
Drugs they prescribed that Part D paid
$7,668
Pharmacies billed $7,668 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
156 generic and fewer than 11 brand-name prescriptions · $7,668 in drug cost · 14 antibiotic prescriptions to 13 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Furosemide | 12 | $32 | $2 |
Year by year
| 2024 | 183 | 69 | None | None | $7,668 |
| 2023 | 54 | 25 | 0% (0) | None | $2,659 |
| 2022 | 149 | 82 | None | 13% | $10,605 |
| 2021 | 261 | 119 | 7% (18) | None | $18,396 |
| 2020 | 244 | 113 | 12% (30) | None | $27,372 |
| 2019 | 551 | 211 | 8% (45) | None | $39,619 |
| 2018 | 265 | 112 | 6% (17) | 10% | $11,563 |
| 2017 | 554 | 101 | 8% (45) | 11% | $29,819 |
| 2016 | 302 | 98 | 14% (43) | 19% | $15,526 |
| 2015 | 94 | 39 | 18% (17) | 13% | $7,157 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2022: 1 drug
| Amoxicillin-Clavulanate Potass | 15 | $142 | $9 |
2021: 4 drugs
| Atorvastatin | 22 | $168 | $8 |
| Amoxicillin-Clavulanate Potass | 20 | $132 | $7 |
| Hydrocodone-Acetaminophen | 12 | $44 | $4 |
| Furosemide | 11 | $32 | $3 |
2020: 6 drugs
| Eliquis | 12 | $5,408 | $451 |
| Amoxicillin-Clavulanate Potass | 18 | $150 | $8 |
| Clopidogrel | 11 | $80 | $7 |
| Hydrocodone-Acetaminophen | 18 | $65 | $4 |
| Prednisone | 11 | $27 | $2 |
| Furosemide | 11 | $27 | $2 |
2019: 14 drugs
| Ceftriaxone | 16 | $3,742 | $234 |
| Vancomycin | 12 | $2,596 | $216 |
| Potassium Chloride | 15 | $1,561 | $104 |
| Atorvastatin | 32 | $338 | $11 |
| Amoxicillin-Clavulanate Potass | 41 | $335 | $8 |
| Amiodarone | 12 | $175 | $15 |
| Levetiracetam | 13 | $147 | $11 |
| Ciprofloxacin | 19 | $147 | $8 |
| Prednisone | 46 | $133 | $3 |
| Hydrocodone-Acetaminophen | 30 | $92 | $3 |
| Clopidogrel | 15 | $89 | $6 |
| Azithromycin | 14 | $87 | $6 |
| Furosemide | 23 | $76 | $3 |
| Carvedilol | 12 | $60 | $5 |
2018: 5 drugs
| Cefuroxime | 14 | $303 | $22 |
| Amoxicillin-Clavulanate Potass | 17 | $117 | $7 |
| Azithromycin | 11 | $90 | $8 |
| Hydrocodone-Acetaminophen | 12 | $86 | $7 |
| Prednisone | 11 | $37 | $3 |
2017: 11 drugs
| Pantoprazole | 29 | $1,610 | $56 |
| Donepezil | 12 | $1,107 | $92 |
| Trospium Chloride | 18 | $1,057 | $59 |
| Gabapentin | 20 | $668 | $33 |
| Alendronate | 13 | $473 | $36 |
| Amlodipine Besylate | 15 | $424 | $28 |
| Hydrocodone-Acetaminophen | 17 | $324 | $19 |
| Lorazepam | 12 | $192 | $16 |
| Allopurinol | 13 | $140 | $11 |
| Levothyroxine | 12 | $138 | $11 |
| Furosemide | 13 | $92 | $7 |
2016: 6 drugs
| Hydrocodone-Acetaminophen | 34 | $718 | $21 |
| Trazodone | 14 | $101 | $7 |
| Metformin | 16 | $87 | $5 |
| Simvastatin | 13 | $76 | $6 |
| Atenolol | 14 | $75 | $5 |
| Prednisone | 11 | $70 | $6 |
2015: 1 drug
| Hydrocodone-Acetaminophen | 15 | $330 | $22 |
Money from drug and device companies
$343 in 2025
| 2025 | 1 | 1 | None | $343 |
| 2023 | 2 | 3 | None | $155 |
| 2022 | 3 | 5 | None | $207 |
| 2021 | 1 | 1 | None | $24 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Heartflow | Ffrct | $343 | 1 payment
|
See the published payment
| Heartflow | Meals · 2025-06-26 | Ffrct | $343 |
See earlier years (2023, 2022, 2021)
2023: $155
| Janssen Scientific Affairs | Xarelto | $122 | 1 payment
|
| AbbVie | Avycaz | $32 | 2 payments
|
2022: $207
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $124 | 1 payment
|
| Abbvie | Dalvance | $57 | 3 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $26 | 1 payment
|
2021: $24
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $24 | 1 payment
|
Professional record
- NPI
- 1104856327
- Licence
- CA C51613California C51613: Current · expires 2027-07-31
- Group
- Stanford Health Care
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Family medicine (207Q00000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2006-07-04
- NPI last updated
- 2024-04-29
- NPI record certified
- 2024-04-29
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 1570 Plateau Ave, Los Altos, CA, 94024